Evidence map›Paper›PMID 40934129›Full record

ArticleJournal of vascular research2026

Immunosuppression Drugs Exhibit Differential Effects on Endothelial Cell Function.

Aly Elezaby, Ryan Dexheimer, David Wu, Sze Yu Chan, Ines Ross Tacco, Ian Y Chen, Nazish Sayed, Karim Sallam

Abstract readComparative Study
In one paragraph

Article in Journal of vascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Aly ElezabyStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Ryan DexheimerStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
David WuStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Sze Yu ChanStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Ines Ross TaccoStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Ian Y ChenStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Nazish SayedStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Karim SallamStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA, sallam@stanford.edu.

Funding

Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA CardiomyopathyR01HL158641 · NHLBI · STANFORD UNIVERSITY · PI SAYED, NAZISH · 2021 to 2025
$2.2M
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicityR01HL161002 · NHLBI · STANFORD UNIVERSITY · PI SAYED, NAZISH · 2022 to 2025
$1.6M
Patient Specific Induced Pluripotent Stem Cell Derived Cardiomyocytes to Define Mechanisms of Electrical-Mechanical Dysfunction in DilatedCardiomyopathyK08HL135343 · NHLBI · STANFORD UNIVERSITY · PI SALLAM, KARIM · 2017 to 2021
$841k
NHLBI NIH HHS K08 HL135343NHLBI NIH HHS R01 HL158641NHLBI NIH HHS R01 HL161002
6 · The paper itself

Abstract

introductionImmunosuppressive medications are widely used to treat patients with neoplasms, autoimmune conditions, and solid organ transplants. Prior studies indicate that immunosuppression drugs can cause adverse vascular remodeling. Given the systemic effects of the drugs, elucidating cell-type-specific drug effects has been challenging.

methodsWe utilized induced pluripotent stem cell-derived endothelial cells to investigate the role of widely used immunosuppression drugs on endothelial cell function.

resultsWe found that among immunosuppression agents, sirolimus reduced basic endothelial cell functions including cell migration, proliferation, acetylated LDL uptake, mitochondrial respiration, and angiogenic properties, while tacrolimus only reduced nitric oxide release.

conclusionsThis model allows for investigation of differential effect of immunosuppression drugs on endothelial function that can elucidate the mechanisms contributing to clinically observed adverse vascular profiles.

Indexed as

Endothelial CellsImmunosuppressive AgentsInduced Pluripotent Stem CellsSirolimusTacrolimusCell MovementCell ProliferationCells, CulturedHumansMitochondriaNeovascularization, PhysiologicNitric OxideImmunosuppressive AgentsNitric OxideSirolimusTacrolimusEndothelial cell functionImmunosuppressionTransplantVascular remodeling

Identifiers

PMID40934129
PMCPMC12772628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.